Table 5.
Main CF components in relation to llama nanobodies
Components | Case study | Value | Description | other |
---|---|---|---|---|
Nature | Llamas | Intrinsic relational instrumental | Domestic camelid | Can be used as lab animal |
Nature contribution to people | VHH nanobodies | Instrumental | Smaller and simpler than those found in humans | VHH fit into smaller and more recessed binding sites on the viral surface |
Anthropogenic assets | Development of llama bio management | Instrumental | Llamas live in a corral near the laboratory | Tamed and trained for special handling (e.g. inoculation, collection of blood samples) |
Laboratories developing therapeutics with llama VHH | Instrumental | State-of-the-art techniques used in molecular biology | ||
Institutions and Governance and other indirect drivers |
International Research institutions National Research Council CONICET, other national institutions (INTA, Milstein, Leloir) |
Instrumental | Research to produce biomedical products |
Many products can be patented Nagoya protocol |
Direct natural drivers | Housing conditions, temperature, food |
Instrumental Relational |
Llamas must be housed and handled with care | In summer, they need to be shorn |
Direct anthropogenic driver |
Research on llama blood | Instrumental | Several laboratories around the world | Techniques for blood collection must follow animal welfare protocols |
Good quality of life | Can provide the cure for a wide range of diseases, including neurodegenerative ones | Instrumental | Therapeutic approaches based on the novel camelid nanobodies | Many people in the world can receive effective treatments based on the molecules of an animal that they do not know and live thousands of kilometers away. Health telecoupling |